Back to results
US 2019/0062298 A1Published application
Indene derivatives and uses thereof
AssigneeMUSC Foundation for Research Development
InventorsNathan G. Dolloff, Reeder M. Robinson, Allen B. Reitz, Haiyan Bian
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of formula (I): including any stereochemically isomeric form thereof, or pharmaceutically acceptable salts thereof, for the treatment of, for example, cancer.
Claims17
A compound of formula (I):
- wherein:
- R1 and R2, independently of each other, are hydrogen, hydroxyl, alkyl, alkoxy, methoxy-acetate, phosphate, valine, Gly-Ser, —OC(O)CH2OC(O)CH3, —OC(O)CH2OCH3, —OCH2C(O)C(CH3)3, —OCH2C(O)NH2 or —OCH2C(O)OH;
- or R1 and R2, together with the carbon atoms to which they are attached, form a 5 to 6-membered ring with one or two ring carbons replaced independently by oxygen or nitrogen;
- R3 is hydrogen, hydroxyl, halogen, cyano, —COOH, —C(O)NH2, —C(O)CH2CH3, —C(O)-alkoxy, alkyl, alkoxy, halo-lower alkyl, carboxyl, amide, ester or nitrile;
- and
- R4 is alkyl or alkenyl, said alkyl or alkenyl optionally mono or bi-substituted independently with hydrogen, halogen, hydroxyl, —OCH2-phenyl, cycloalkyl, —OCH2-halophenyl or —OCH2-phenylhaloalkyl,
- or a pharmaceutically acceptable salt thereof.
4 more elements
A compound, wherein said compound is:
- or a pharmacetically acceptable salt thereof.
Dependencies are inferred from the claim text.